SE8406263D0 - PROCEDURE FOR THE PREPARATION OF A NEW MEDICINE USEFUL HEMIN ASSOCIATION - Google Patents
PROCEDURE FOR THE PREPARATION OF A NEW MEDICINE USEFUL HEMIN ASSOCIATIONInfo
- Publication number
- SE8406263D0 SE8406263D0 SE8406263A SE8406263A SE8406263D0 SE 8406263 D0 SE8406263 D0 SE 8406263D0 SE 8406263 A SE8406263 A SE 8406263A SE 8406263 A SE8406263 A SE 8406263A SE 8406263 D0 SE8406263 D0 SE 8406263D0
- Authority
- SE
- Sweden
- Prior art keywords
- hemin
- preparation
- association
- procedure
- new medicine
- Prior art date
Links
- 229940025294 hemin Drugs 0.000 title abstract 6
- 238000002360 preparation method Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- BTIJJDXEELBZFS-UHFFFAOYSA-K hemin Chemical compound [Cl-].[Fe+3].[N-]1C(C=C2C(=C(C)C(C=C3C(=C(C)C(=C4)[N-]3)C=C)=N2)C=C)=C(C)C(CCC(O)=O)=C1C=C1C(CCC(O)=O)=C(C)C4=N1 BTIJJDXEELBZFS-UHFFFAOYSA-K 0.000 title 1
- BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 abstract 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract 2
- 208000007502 anemia Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- KDXKERNSBIXSRK-UHFFFAOYSA-M lysinate Chemical compound NCCCCC(N)C([O-])=O KDXKERNSBIXSRK-UHFFFAOYSA-M 0.000 abstract 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 1
- 229930064664 L-arginine Natural products 0.000 abstract 1
- 235000014852 L-arginine Nutrition 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 239000011877 solvent mixture Substances 0.000 abstract 1
- 238000003756 stirring Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
- C07F15/025—Iron compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Abstract
A method for the preparation of a new, physiologically active, water-soluble complex compound of hemin arginate or hemin lysinate in which crystalline hemin and the amino acid L-arginine or L-lysine, in a molar proportion of 1:3, are allowed to react at room temperature under vigorous stirring for 10 to 15 hours in a solvent mixture of acetone and water 300:20 v/v. The hemin arginate or hemin lysinate thus formed is a powdery, stable compound suitable for use as raw material in tablets or capsules or as dry substance for preparation of injections for treatment of various types of anemia, particularly anemias associated with prophyria.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB08431398A GB2168354B (en) | 1984-12-12 | 1984-12-12 | Hemin compound |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8406263D0 true SE8406263D0 (en) | 1984-12-10 |
SE8406263L SE8406263L (en) | 1986-06-11 |
SE457958B SE457958B (en) | 1989-02-13 |
Family
ID=10571084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8406263A SE457958B (en) | 1984-12-12 | 1984-12-10 | WATER-SOLUBLE HEMIN ARGINATE OR HEMIN-LYSINATE SOCIETY, PROCEDURE FOR PREPARING THEREOF AND USING THEREOF FOR MANUFACTURE OF MEDICAL COMPOSITIONS |
Country Status (12)
Country | Link |
---|---|
JP (1) | JPH0647541B2 (en) |
AT (1) | AT389308B (en) |
BE (1) | BE901319A (en) |
CA (1) | CA1242713A (en) |
CH (1) | CH666273A5 (en) |
DE (1) | DE3446887C2 (en) |
FR (1) | FR2574662B1 (en) |
GB (1) | GB2168354B (en) |
LU (1) | LU85716A1 (en) |
NL (1) | NL192682C (en) |
SE (1) | SE457958B (en) |
SU (1) | SU1384188A3 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0645681B2 (en) * | 1986-02-05 | 1994-06-15 | 美浜 久春 | Modified hem |
IT1245890B (en) * | 1991-04-12 | 1994-10-25 | Alfa Wassermann Spa | PHARMACEUTICAL FORMULATIONS FOR ORAL USE GASTRORESANTS CONTAINING BILE ACIDS. |
US7994217B2 (en) | 2002-05-02 | 2011-08-09 | Xanodyne Pharmaceuticals, Inc. | Prenatal multivitamin/multimineral supplement |
RU2611636C1 (en) * | 2016-02-25 | 2017-02-28 | Федеральное государственное бюджетное образовательное учреждение высшего образования Новосибирский государственный аграрный университет | Hematogen |
RU2671633C1 (en) * | 2017-11-30 | 2018-11-06 | Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ" | Highly effective hematogen |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2912M (en) * | 1963-07-24 | 1964-11-09 | Rech S Pharma E R P H A R Soc | Procaine hematoporphyrinate dihydrochloride. |
JPS4930521A (en) * | 1972-07-17 | 1974-03-19 | ||
JPS5144623A (en) * | 1974-10-14 | 1976-04-16 | Green Cross Corp | CHUSHAYOASECHIRUSARICHIRUSANENNO SEIHO |
DE2527158A1 (en) * | 1975-06-18 | 1976-12-23 | Herz Eberhard | MEDICINAL PRODUCTS FOR THE TREATMENT OF INFECTIOUS DISEASES AND INFLAMMATION IN HUMAN AND VETERINAL MEDICINE THAT CANNOT BE DETECTED BY MICROORGANISMS |
JPS6021570B2 (en) * | 1978-07-04 | 1985-05-28 | 三共株式会社 | Method for manufacturing high concentration preparations of DOPAs |
JPS5780317A (en) * | 1980-11-05 | 1982-05-19 | Sumitomo Chem Co Ltd | Preparation of pharmaceutical composition for injection |
JPS57209211A (en) * | 1981-06-18 | 1982-12-22 | Shiseido Co Ltd | Antimicrobial composition |
-
1984
- 1984-12-10 AT AT0390784A patent/AT389308B/en not_active IP Right Cessation
- 1984-12-10 SE SE8406263A patent/SE457958B/en not_active IP Right Cessation
- 1984-12-12 GB GB08431398A patent/GB2168354B/en not_active Expired
- 1984-12-13 NL NL8403782A patent/NL192682C/en not_active IP Right Cessation
- 1984-12-14 FR FR848419134A patent/FR2574662B1/en not_active Expired - Lifetime
- 1984-12-19 BE BE0/214195A patent/BE901319A/en not_active IP Right Cessation
- 1984-12-21 DE DE3446887A patent/DE3446887C2/en not_active Expired - Fee Related
- 1984-12-28 LU LU85716A patent/LU85716A1/en unknown
-
1985
- 1985-01-07 CH CH45/85A patent/CH666273A5/en not_active IP Right Cessation
- 1985-01-09 SU SU3831925A patent/SU1384188A3/en active
- 1985-01-23 JP JP60009302A patent/JPH0647541B2/en not_active Expired - Fee Related
- 1985-02-06 CA CA000473658A patent/CA1242713A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
BE901319A (en) | 1985-04-16 |
NL192682B (en) | 1997-08-01 |
SU1384188A3 (en) | 1988-03-23 |
DE3446887A1 (en) | 1986-07-03 |
JPH0647541B2 (en) | 1994-06-22 |
DE3446887C2 (en) | 1994-05-05 |
JPS61172821A (en) | 1986-08-04 |
GB8431398D0 (en) | 1985-01-23 |
SE8406263L (en) | 1986-06-11 |
ATA390784A (en) | 1989-04-15 |
LU85716A1 (en) | 1985-07-24 |
FR2574662B1 (en) | 1990-03-02 |
NL8403782A (en) | 1986-07-01 |
NL192682C (en) | 1997-12-02 |
AT389308B (en) | 1989-11-27 |
FR2574662A1 (en) | 1986-06-20 |
GB2168354A (en) | 1986-06-18 |
SE457958B (en) | 1989-02-13 |
CA1242713A (en) | 1988-10-04 |
GB2168354B (en) | 1988-12-07 |
CH666273A5 (en) | 1988-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT45236A (en) | Process for producing new benzimidazole derivatives | |
CA1139768A (en) | Mixed salts of essential or semi-essential amino acids and nitrogen-free analogues thereof and uses in treatment of renal and hepatic disorders | |
NO176101C (en) | Analogous Process for the Preparation of Therapeutically Active N- (3-hydroxy-4-piperidinyl) (dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin) carboxamide derivatives | |
NO169347C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE POLYPEPTIDES | |
ES2070994T3 (en) | DOPAMINE PROFARMACO. | |
HUP9903455A2 (en) | Stable,non-hygroscopic salts of l(-)carnitine and alkanoyl l(-) carnitines,a process for their preparation and solid,orally administrable compositions containing such salts | |
IL84409A0 (en) | Imidazolidinone derivatives,their preparation and pharmaceutical compositions containing them | |
US3275643A (en) | Allantoin-pantothenate compounds | |
SE8406263L (en) | PROCEDURE FOR THE PREPARATION OF A NEW MEDICINE USEFUL HEMIN ASSOCIATION | |
US4973553A (en) | Salt or organogermanium compound and medicine containing the same | |
WO1986002555A3 (en) | Amino acid solution-containing drug for the treatment of cancerous diseases and preparation process thereof | |
NO883520D0 (en) | PROCEDURE FOR THE PREPARATION OF AN INJECTION PREPARATION. | |
GB1333524A (en) | Penicilloic acid derivatives | |
KR0144442B1 (en) | Water soluble bithmuth compound and process of preparation forthereof | |
DK220088D0 (en) | THIADIASOLGUANIDINES, PROCEDURES FOR PREPARING THEREOF AND AFRMACEUTICAL PREPARATIONS CONTAINING THESE RELATIONSHIPS | |
DK583884A (en) | PROCEDURE FOR MAKING A HOME RELATIONSHIP | |
EP0157284A3 (en) | Theophylline-7-acetic acid ester of d,l-trans-sobrerol having mucosecretolytic-fluidizing and antibronchospastic activity, a process for its preparation and pharmaceutical compositions thereof | |
SU606242A1 (en) | "dimotziphon" anti-leprose preparation | |
Hay et al. | The uncatalysed and the copper (II) promoted hydrolysis of 4-nitrophenyl L-leucinate | |
JPS62252793A (en) | Organic germanium compound and drug containing same | |
GB2073192A (en) | Cefadroxil Salts | |
EP0010830A3 (en) | Dehydropeptides | |
TH9830EX (en) | Pirolo's derivatives (2, 1 - B) thiazole | |
JPS55164668A (en) | Alpha-amino-beta-chloroethane-sulfonic acid or its salt | |
TH18739EX (en) | Risperidone Pamoet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8406263-7 Format of ref document f/p: F |
|
NUG | Patent has lapsed | ||
NUG | Patent has lapsed |